146 related articles for article (PubMed ID: 7338581)
21. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
[TBL] [Abstract][Full Text] [Related]
22. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
Heinrich F; Loew D; Dýcka J
Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy and safety of bumetanide and furosemide in long-term treatment of edema due to congestive heart failure.
Dixon DW; Barwolf-Gohlke C; Gunnar RM
J Clin Pharmacol; 1981; 21(11):680-7. PubMed ID: 7338579
[TBL] [Abstract][Full Text] [Related]
24. [The salidiuretic interaction of angiotensin II and furosemide in ascitogenic hepatic cirrhosis].
Ventura E; Zeneroli ML
Folia Endocrinol; 1969 Dec; 22(4):345-53. PubMed ID: 4329093
[No Abstract] [Full Text] [Related]
25. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
[TBL] [Abstract][Full Text] [Related]
26. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
Buligescu L; Candiori R
Med Interna (Bucur); 1970 May; 22(5):573-92. PubMed ID: 5426383
[No Abstract] [Full Text] [Related]
27. Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
Ng TM; Konopka E; Hyderi AF; Hshieh S; Tsuji Y; Kim BJ; Han SY; Phan DH; Jeng AI; Lou M; Elkayam U
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):345-53. PubMed ID: 23538300
[TBL] [Abstract][Full Text] [Related]
28. Treatment of nephrotic edema with bumetanide.
Lemieux G; Beauchemin M; Gougoux A; Vinay P
Can Med Assoc J; 1981 Nov; 125(10):1111-2, 1117. PubMed ID: 7034916
[TBL] [Abstract][Full Text] [Related]
29. Loop diuretic therapy in liver cirrhosis with ascites.
Laffi G; La Villa G; Carloni V; Foschi M; Bartoletti L; Quartini M; Gentilini P
J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S51-8. PubMed ID: 7506337
[TBL] [Abstract][Full Text] [Related]
30. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
[TBL] [Abstract][Full Text] [Related]
31. [Furosemide in treatment of the edema syndrome in cirrhotics].
Nuti M
Clin Ter; 1965 Sep; 34(6):507-14. PubMed ID: 5852544
[No Abstract] [Full Text] [Related]
32. Use of bumetanide in the treatment of ascites due to liver disease.
Moult PJ; Lunzer MR; Trash DB; Sherlock S
Postgrad Med J; 1975; 51 Suppl 6():81-84. PubMed ID: 1105537
[No Abstract] [Full Text] [Related]
33. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
Grassi V; Porcellati C; Corea L; Todisco T
Minerva Nefrol; 1968; 15(4):258-60. PubMed ID: 5745815
[No Abstract] [Full Text] [Related]
34. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
Gentilini P; Casini-Raggi V; Di Fiore G; Romanelli RG; Buzzelli G; Pinzani M; La Villa G; Laffi G
J Hepatol; 1999 Apr; 30(4):639-45. PubMed ID: 10207805
[TBL] [Abstract][Full Text] [Related]
35. An optimal diuretic regimen for cirrhotic ascites. A controlled trial evaluating safety and efficacy of spironolactone and furosemide.
Fuller RK; Khambatta PB; Gobezie GC
JAMA; 1977 Mar; 237(10):972-5. PubMed ID: 319263
[TBL] [Abstract][Full Text] [Related]
36. [Controlled clinical trial of the association of furosemide and triamterene].
Azzi E; Perraro F
Clin Ter; 1971 Mar; 56(6):501-22. PubMed ID: 5131091
[No Abstract] [Full Text] [Related]
37. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
[No Abstract] [Full Text] [Related]
38. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
[TBL] [Abstract][Full Text] [Related]
39. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
[TBL] [Abstract][Full Text] [Related]
40. Long-term bumetanide treatment of patients with edema due to renal disease. Cooperative studies.
Stone WJ; Bennett WM; Cutler RE
J Clin Pharmacol; 1981; 21(11):587-980. PubMed ID: 7040492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
